MURRAY RICHARD /CA/ (CEO and President) sold 17.2% of their position (39.23K shares) of JOUNCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $72.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/6/2023ACC: 0001640455-23-000053
DirectorOfficer· CEO and President
Since Sep 2018
-39.23K
Net shares
Net seller
$72.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
39.23K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−39.23K
Price / share
$1.85
Trade value
$72.57K
% of position
17.2%
4/4/2023
228.01K→188.78K
Total
Net shares
−39.23K
Net value
-$72.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/4/2023 | S · Sale | −39.23K | $1.85 | $72.57K | 17.2% | 228.01K | 188.78K |
| Total | −39.23K | -$72.57K | ||||||
Derivative Transactions0
No derivative transactions reported